Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Despite Shenyang Xingqi Pharmaceutical Ltd's weak recent rev...

Despite Shenyang Xingqi Pharmaceutical Ltd's weak recent revenue performance, the high P/S ratio points to investors holding stocks, anticipating significant revenue recovery. But with forecasted growth mirrored by the industry, the current ratio may not be sustainable without improved performance.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more
Translate
Report
4941 Views
Comment
Sign in to post a comment